Heart transplant patients survive thanks to new devices, drugs
Implanted devices helped keep Chris Einhorn active for 17 months until she had heart transplant surgery in August. She was able to leave the hospital nine days after the operation.
The HeartMate II was approved to keep patients healthy until transplantation. But the device theoretically could work for at least 17 years, according to the head of the company that makes it.
Powered by BLOX Content Management System from TownNews.com.